Demographic

Close Menu

View all - Cardiovascular Renal Metabolic Chronic Kidney Disease Diabetes Metabolic dysfunction-associated fatty liver disease (MAFLD) Obesity

View all - COVID-19

View all - CV Disease in Special Populations Cardio-oncology

View all - Demographic Age Ethnicity Gender

View all - Digital Health

View all - Electrophysiology & Arrhythmia

View all - Guidelines & Statements

View all - Heart Failure Amyloidosis Cardiomyopathy Co-morbidities Devices Imaging and Diagnosis

View all - Imaging & Diagnostics Echocardiography & Ultrasound

View all - Intervention

View all - MI/ACS

View all - Prevention & Chronic Conditions Atherosclerosis and Hyperlipidemia Cardiac Rehabilitation Programmes Coronary Artery Disease Hypertension Lifestyle

View all - Vascular Disease and Surgery Carotid Artery Disease Peripheral Artery Disease - General

Most Recent Most Viewed

Topics

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Video

Cardiovascular Renal Metabolic

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s

Clinical Presentations and Treatment: Focus on CKD and CVD

Video

Demographic

Prevention & Chronic Conditions

Clinical Presentations and Treatment: Focus on CKD and CVD

Stephan Von Haehling, , , et al

Watch time: 1h 10s

HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Video

Demographic

Heart Failure

HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Harriette Van Spall, Mark Petrie

Watch time: 15m 26s

EASD 23: Epidemiologic Trends & Disparities in Diabetes Risk Among LGBTQ+ Population

Video

Demographic

Prevention & Chronic Conditions

EASD 23: Disparities in Diabetes Risk Among LGBTQ+ Patients

Watch time: 7m 26s

Video

Demographic

Addressing CV Health Disparities in Sexual Minority Individuals

Watch time: 14m 21s

Video Series

Demographic

Heart Failure

SGLT2 Inhibition in Heart Failure: New Updates

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

AHA 22: Efficacy of Empagliflozin in Black vs White Pts With Heart Failure

Video

Demographic

Heart Failure

AHA 22: Efficacy of Empagliflozin in Black vs White Pts With HF

Subodh Verma

Watch time: 5m

Video Series

Demographic

Heart Failure

SGLT2 Inhibition in Heart Failure: New Updates

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Video

Demographic

Heart Failure

AHA 22: Efficacy of Empagliflozin in Black vs White Pts With HF

Subodh Verma

Watch time: 5m

Video

Demographic

Addressing CV Health Disparities in Sexual Minority Individuals

Watch time: 14m 21s

Video

Demographic

Prevention & Chronic Conditions

EASD 23: Disparities in Diabetes Risk Among LGBTQ+ Patients

Watch time: 7m 26s

Video

Demographic

Heart Failure

HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Harriette Van Spall, Mark Petrie

Watch time: 15m 26s

Video

Cardiovascular Renal Metabolic

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s

Video

Demographic

Prevention & Chronic Conditions

Clinical Presentations and Treatment: Focus on CKD and CVD

Stephan Von Haehling, , , et al

Watch time: 1h 10s

Media

Video Series

Demographic

Heart Failure

SGLT2 Inhibition in Heart Failure: New Updates

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Media

Video

Cardiovascular Renal Metabolic

ACC 2025: Lifetime Benefit by Control of Modifiable Risk Factors

Christina Magnussen

Watch time: 2m 46s

Video

Demographic

Heart Failure

AHA 22: Efficacy of Empagliflozin in Black vs White Pts With HF

Subodh Verma

Watch time: 5m

Video

Demographic

Prevention & Chronic Conditions

Clinical Presentations and Treatment: Focus on CKD and CVD

Stephan Von Haehling, , , et al

Watch time: 1h 10s

Video

Demographic

Heart Failure

HFA 24 Late-Breaker Wrap Up with Dr Van Spall & Dr Petrie

Harriette Van Spall, Mark Petrie

Watch time: 15m 26s

Video Series

Demographic

Heart Failure

SGLT2 Inhibition in Heart Failure: New Updates

Subodh Verma, John JV McMurray, Xiaowen “Wendy” Wang, et al

Watch time: 2h 22m (10 videos)

Video

Demographic

Prevention & Chronic Conditions

EASD 23: Disparities in Diabetes Risk Among LGBTQ+ Patients

Watch time: 7m 26s

Video

Demographic

Addressing CV Health Disparities in Sexual Minority Individuals

Watch time: 14m 21s

Cardiovascular Renal Metabolic

COVID-19

CV Disease in Special Populations

Demographic

Digital Health

Electrophysiology & Arrhythmia

Guidelines & Statements

Heart Failure

Imaging & Diagnostics

Intervention

MI/ACS

Prevention & Chronic Conditions

Vascular Disease and Surgery

Demographic

Media

Media

Articles